Select Language

EREG

EREG Overview

English Name	Epiregulin	Approved Drugs	0
Drugs in Clinical Trials	2	Target Synonym	Epiregulin，Ep，EREG，EPR，ER，Proepiregulin
Highest Development Stage	Phase 2 Clinical

English Name	Epiregulin
Target Synonym	Epiregulin，Ep，EREG，EPR，ER，Proepiregulin
Approved Drugs	0
Drugs in Clinical Trials	2
Highest Development Stage	Phase 2 Clinical

EREG Product List

Product Category
Protein (1)
Product Status
Launched (1)
Species
Human (1)
Tag
Fc Tag (1)
Conjugate
Unconjugated (1)

Cat. No.	Species	Host	Product Description	Structure	Purity	Feature
ERG-H5264	Human	HEK293	Human EREG Protein, Fc Tag

Total: 1

EREG Background

EREG is a ligand of the epidermal growth factor receptor (EGFR) and the structurally related erb-b2 receptor tyrosine kinase 4 (ERBB4), which stimulates tyrosine phosphorylation of EGFR and ERBB4. EREG may be involved in a wide range of biological processes including inflammation, wound healing, oocyte maturation, and cell proliferation. Additionally, EREG may promote the progression of cancers of various human tissue.

EREG Synonyms

EPR, ER, Ep

Clinical Drug Information

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
Fepixnebart	LY-3016859	Phase 2 Clinical	Eli Lilly And Company	Diabetic Nephropathies; Diabetic Neuropathies; Low Back Pain; Osteoarthritis; Osteoarthritis, Knee	Details
Epiregulin Antibody	LY3848575; LY-3848575	Phase 2 Clinical	Eli Lilly And Company	Neuralgia; Polyneuropathies	Details